Qi Zhang Tatarata

10PUBLICATIONS
57CO-AUTHORS
Molecular targetsInnate immunityHaematological tumoursBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 18, 2024
BCL-2 inhibition in acute myeloid leukemia: resistance and combinations.

Qi Zhang Tatarata, Zhe Wang, Marina Konopleva

|Feb 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia.

Seemana Bhattacharya, Sujan Piya, Huaxian Ma

|Apr 28, 2022
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.

Tianyu Cai, Agnès Gouble, Kathryn L Black

|Feb 21, 2022
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.

Qi Zhang, Bridget Riley-Gillis, Lina Han

Pageof 2